Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

General Notices

Notice of Memorandum of Understanding Between NIH and NASA Concerning Laboratory Animal Welfare
(NOT-OD-20-095)
National Institutes of Health

Request for Information (RFI): Invitation to Comment on Updates to NIH Research Plans on Down Syndrome
(NOT-HD-20-013)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Office of the Director, NIH
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Notice Of Changes to Funding Opportunities

Notice of NHLBI Participation in PAR-20-097 Biomedical Knowledgebase (U24 Clinical Trials Not Allowed)
(NOT-HL-20-739)
National Heart, Lung, and Blood Institute

Notice of NHLBI Participation in PAR-20-089 Biomedical Data Repository (U24 Clinical Trials Not Allowed)
(NOT-HL-20-740)
National Heart, Lung, and Blood Institute

Notice Of Intent to Publish

Notice of Intent to Publish a Funding Opportunity Announcement for PHS 2020 Omnibus Solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
(NOT-OD-20-099)
National Institutes of Health

Notice Of Special Interest

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences
(NOT-OD-20-097)
Office of Behavioral and Social Sciences Research
National Center for Complementary and Integrative Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
Office of Disease Prevention
Office of Research on Women's Health

Notice of Special Interest (NOSI): Research Supplements to Promote Diversity in Environmental influences on Child Health Outcomes (ECHO) Program Research (Admin Supp - Clinical Trial Not Allowed)
(NOT-OD-20-098)
National Institutes of Health

Funding Opportunities

Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed)
(PAR-20-165)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Library of Medicine
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Standard dates apply The first standard application due date for this FOA is June 5, 2020.

Implementation Research to Improve Case Finding, Cascade Screening, and Treatment for Familial Hypercholesterolemia (FH) (R61/R33 Clinical Trial Required)
(RFA-HL-22-006)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): March 8, 2021